Xtant医控股 XTNT 深 沪
等待开盘 03-26 09:30:00 美东时间
0.5631
+0.003
+0.55%
华盛通- 最 高0.5786
- 今 开0.578
- 成交量 8.07万股
- 最 低 0.555
- 昨 收 0.56
- 总市值 7883.64万
- 52周最高 0.95
- 市盈率 静 --
- 换手率 0.06%
- 52周最低 0.3401
- 委 比 33.33%
- 总股本 1.40亿
- 历史最高 471.60
- 量 比 0.37
- 振 幅 4.21%
- 历史最低 0.331
- 每 手 1
- 风险率 0.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Azitra (AMEX:AZTR) stock moved upwards by 87.3% to $0.33 during Friday...
03-20 20:05
Xtant Medical Receives $10.7M Related To Companion Spine's Purchase Of Xtant's Coflex Assets And Paradigm OUS Businesses, Bringing Total Price For Two Divestitures To $21.4M
Xtant received $10.7 million in satisfaction of unsecured promissory note issued to Xtant by Companion Spine plus related working capital adjustmentsBELGRADE, Mont., March 2, 2026 /PRNewswire/ -- Xtant Medical Holdings,
03-02 21:10
Xtant Medical Finalizes Companion Spine Transactions
Xtant received $10.7 million in satisfaction of unsecured promissory note issued to Xtant by Companion Spine plus related working capital adjustments BELGRADE, Mont., March 2, 2026 /PRNewswi...
03-02 21:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Vyome Holdings (NASDAQ:HIND) stock increased by 16.1% to $2.23 during ...
02-02 20:05
Xtant Medical Launches Next-Generation nanOss Strata Synthetic Bone Graft
Xtant Medical Holdings Inc. has announced the commercial launch of its next-generation synthetic bone graft, nanOss Strata™, expanding its orthobiologics portfolio. The new product is designed to more...
2025-12-11 21:01
Xtant Medical Completes Sale of Coflex Assets and Paradigm OUS Businesses to Companion Spine
Xtant Medical Holdings, Inc. has completed the sale of certain businesses to Companion Spine for approximately $19.2 million, consisting of $11.0 million in cash and $8.2 million in short-term seller ...
2025-12-02 05:05
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
BTIG Maintains Buy on Xtant Medical Hldgs, Lowers Price Target to $1.5
BTIG analyst Ryan Zimmerman maintains Xtant Medical Hldgs (AMEX:XTNT) with a Buy and lowers the price target from $2 to $1.5.
2025-11-12 00:32
Xtant Medical Hldgs Affirms FY2025 Sales Guidance of $131.000M-$135.000M vs $129.950M Est
Xtant Medical Hldgs (AMEX:XTNT) affirms FY2025 sales outlook from $131.000 million-$135.000 million to $131.000 million-$135.000 million vs $129.950 million estimate.
2025-11-11 06:58
Xtant Medical Hldgs Q3 EPS $0.01 Beats $(0.01) Estimate, Sales $33.300M Beat $32.700M Estimate
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.01) by 300 percent. This is a 125 percent increase over losses of $(0.04) per share from the
2025-11-11 05:39
